2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in France Leader Award
2016 - Member of Academia Europaea
Pulmonary hypertension, Internal medicine, Cardiology, Immunology and Pathology are his primary areas of study. His study in Pulmonary hypertension is interdisciplinary in nature, drawing from both Respiratory disease, Lung, Disease, Pulmonary artery and Associated Pulmonary Arterial Hypertension. As a member of one scientific family, he mostly works in the field of Disease, focusing on Intensive care medicine and, on occasion, Pediatrics and Pulmonary embolism.
His research integrates issues of Endocrinology and Surgery in his study of Internal medicine. His work deals with themes such as Gastroenterology, Cohort study and Cohort, which intersect with Surgery. In his work, Adverse effect is strongly intertwined with Bosentan, which is a subfield of Cardiology.
His primary scientific interests are in Internal medicine, Pulmonary hypertension, Cardiology, Pathology and Pulmonary artery. Marc Humbert has researched Internal medicine in several fields, including Gastroenterology, Endocrinology and Surgery. In his study, MEDLINE is inextricably linked to Intensive care medicine, which falls within the broad field of Pulmonary hypertension.
Marc Humbert interconnects Lung transplantation and Bosentan in the investigation of issues within Cardiology. His Pathology study combines topics from a wide range of disciplines, such as Inflammation, Immunology and BMPR2. Particularly relevant to Immune system is his body of work in Immunology.
The scientist’s investigation covers issues in Internal medicine, Pulmonary hypertension, Cardiology, Pulmonary artery and Vascular resistance. His Internal medicine research integrates issues from Gastroenterology and Endocrinology. His Pulmonary hypertension research is multidisciplinary, incorporating elements of Hypoxia, Intensive care medicine, Vascular remodelling in the embryo, Lung and Disease.
Marc Humbert has included themes like Inflammation, Fibrosis, Pathology and Transplantation in his Lung study. His study brings together the fields of Complication and Cardiology. His Vascular resistance research incorporates themes from Right ventricular hypertrophy, Pharmacology, Associated Pulmonary Arterial Hypertension and Angioplasty.
His scientific interests lie mostly in Internal medicine, Pulmonary hypertension, Cardiology, Pulmonary artery and Asthma. His biological study spans a wide range of topics, including Gastroenterology and Endocrinology. His Pulmonary hypertension study incorporates themes from Hypoxia, Angioplasty, Disease, Pathology and Gene.
His Cardiology research includes elements of Lung volumes and Complication. His work focuses on many connections between Pulmonary artery and other disciplines, such as Vascular resistance, that overlap with his field of interest in Pharmacology and Vascular remodelling in the embryo. The various areas that Marc Humbert examines in his Asthma study include Exacerbation, Family medicine, Omalizumab, Immunoglobulin E and Placebo.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly.
The Journal of Allergy and Clinical Immunology (2012)
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Galiè N;Hoeper Mm;Humbert M;Torbicki A.
European Heart Journal (2009)
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg.
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Nazzareno Galiè;Marc Humbert;Jean-Luc Vachiery;Simon Gibbs.
European Heart Journal (2016)
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Stavros V. Konstantinides;Adam Torbicki;David Fitzmaurice;J. Simon.
European Heart Journal (2014)
Pulmonary arterial hypertension in France: results from a national registry.
Marc Humbert;Olivier Sitbon;Ari Chaouat;Michèle Bertocchi.
American Journal of Respiratory and Critical Care Medicine (2006)
Treatment of Pulmonary Arterial Hypertension
Marc Humbert;Olivier Sitbon;Gérald Simonneau.
The New England Journal of Medicine (2004)
Cellular and molecular pathobiology of pulmonary arterial hypertension.
Marc Humbert;Nicholas W Morrell;Stephen L Archer;Kurt R Stenmark.
Journal of the American College of Cardiology (2004)
Long-Term Intravenous Epoprostenol Infusion in Primary Pulmonary Hypertension Prognostic Factors and Survival
Olivier Sitbon;Marc Humbert;Hilario Nunes;Florence Parent.
Journal of the American College of Cardiology (2002)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Marius M. Hoeper;Marc Humbert;Adam Torbicki;Jean-Luc Vachiery.
European Respiratory Journal (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: